Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,150 | -21,780 | -8,306 | -28,284 | -22,017 |
| Depreciation Amortization | 304 | 181 | 98 | 86 | 340 |
| Accounts payable and accrued liabilities | -648 | -825 | 25 | -21 | 54 |
| Other Working Capital | -2,230 | -1,949 | -1,830 | 2,945 | 2,171 |
| Other Operating Activity | -2,152 | 957 | -1,543 | -17,595 | -12,683 |
| Operating Cash Flow | $-32,876 | $-23,416 | $-11,556 | $-42,869 | $-32,135 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -81 | -34 | -18 | -57 | -48 |
| Net Acquisitions | N/A | -534 | N/A | -2,415 | -2,315 |
| Other Investing Activity | -735 | 0 | -500 | -3,056 | -3,056 |
| Investing Cash Flow | $-816 | $-568 | $-518 | $-5,528 | $-5,419 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,902 | -1,914 | -947 | -1,766 | -908 |
| Common Stock Issued | 47,756 | 47,527 | 42,231 | 26,026 | 15,322 |
| Financing Cash Flow | $44,854 | $45,613 | $41,284 | $24,260 | $14,414 |
| Beginning Cash Position | 23,650 | 23,650 | 23,650 | 47,787 | 47,787 |
| End Cash Position | 34,812 | 45,279 | 52,860 | 23,650 | 24,647 |
| Net Cash Flow | $11,162 | $21,629 | $29,210 | $-24,137 | $-23,140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,876 | -23,416 | -11,556 | -42,869 | -32,135 |
| Capital Expenditure | -81 | -34 | -18 | -57 | -48 |
| Free Cash Flow | -32,957 | -23,450 | -11,574 | -42,926 | -32,183 |